<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00979147</url>
  </required_header>
  <id_info>
    <org_study_id>MVA-3946B</org_study_id>
    <nct_id>NCT00979147</nct_id>
  </id_info>
  <brief_title>Comparison of a Metal Backed Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty</brief_title>
  <official_title>A Randomized Prospective Level 1 Comparison of a Modular Polished Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minneapolis Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Depuy, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Minneapolis Veterans Affairs Medical Center</source>
  <brief_summary>
    <textblock>
      This study is designed to compare prospectively, in a randomized Level 1 evidence fashion,&#xD;
      the clinical, functional, and radiographic results of a modular polished tibial (MPT) tray&#xD;
      with a moderately cross-linked polyethylene (XLK) insert to an all-polyethylene tibial (APT)&#xD;
      design with GVF polyethylene. Comparing these two designs will afford us information in the&#xD;
      following areas:&#xD;
&#xD;
        1. Does a MPT/XLK design have improved wear characteristics over a nonmodular APT/GVF&#xD;
           design?&#xD;
&#xD;
        2. Is there a clear clinical advantage to the MPT/XLK design in certain patient populations&#xD;
           that justify its use over the APT/GVF design?&#xD;
&#xD;
      Answering these questions will allow surgeons to use both designs appropriately in different&#xD;
      demand populations.&#xD;
&#xD;
      This study is designed to address the questions of whether an MPT/XLK design offers&#xD;
      improvement in wear characteristics, Knee Society scores, KOOS, WOMAC, SF-36, or radiographic&#xD;
      measures, over an APT design. The investigator's primary hypothesis is that there will be no&#xD;
      difference in these outcome measures at a minimum two year follow-up. A secondary hypothesis&#xD;
      based on the long-term follow-up of this group, up to twenty years, is that there will be no&#xD;
      difference in implant survival.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Summary is detailed&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI/study coordinator retired due to personal family health matters; study sponsor withdrew&#xD;
    funding. Study terminated and no data collected or analyzed&#xD;
  </why_stopped>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical and Functional Outcomes Based on Standardized Validated TKA Outcome Instruments (KSS, KOOS, WOMAC, SF-36)</measure>
    <time_frame>2 year follow-up intervals up to 20 years</time_frame>
    <description>Patient recorded outcome measures as noted</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wear Characteristics of the Standard GVF Polyethylene vs. the Moderately Cross-linked XLK Polyethylene</measure>
    <time_frame>2 year followup intervals to 20 years</time_frame>
    <description>Wear characteristics as above</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Modular Metal Tibial Baseplate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All Polyethylene Tibial Baseplate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TKA surgery with modular polished tibial baseplate/XLK design</intervention_name>
    <description>TKA surgery with modular polished tibial baseplate/XLK design</description>
    <arm_group_label>Modular Metal Tibial Baseplate</arm_group_label>
    <other_name>P.F.C.® Sigma Knee System with modular XLK poly</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TKA surgery with the nonmodular APT/GVF design</intervention_name>
    <description>TKA surgery with the nonmodular APT/GVF design</description>
    <arm_group_label>All Polyethylene Tibial Baseplate</arm_group_label>
    <other_name>P.F.C. ® Sigma Knee with an all-poly GVF tibia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>P.F.C.® Sigma Knee System</intervention_name>
    <description>P.F.C.® Sigma Knee System with modular XLK poly</description>
    <arm_group_label>Modular Metal Tibial Baseplate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>P.F.C.® Sigma Knee System</intervention_name>
    <description>P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
    <arm_group_label>All Polyethylene Tibial Baseplate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  generally accepted clinical and radiographic criteria for total knee arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant angular or bony deformity necessitating structural bone grafting or more&#xD;
             extensive modular designs will be excluded at the discretion of the principle&#xD;
             investigator&#xD;
&#xD;
          -  Routine contraindications to TKA (active sepsis, Charcot arthropathy)&#xD;
&#xD;
          -  Patients whose mental function preclude them from responding to our standard&#xD;
             questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terence J Gioe, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minneapolis VAMC</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <results_first_submitted>September 3, 2020</results_first_submitted>
  <results_first_submitted_qc>September 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 7, 2020</results_first_posted>
  <last_update_submitted>September 3, 2020</last_update_submitted>
  <last_update_submitted_qc>September 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minneapolis Veterans Affairs Medical Center</investigator_affiliation>
    <investigator_full_name>Terence J. Gioe, M.D.</investigator_full_name>
    <investigator_title>Chief of Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <keyword>knee arthritis</keyword>
  <keyword>total knee arthroplasty</keyword>
  <keyword>total knee replacement</keyword>
  <keyword>metal backed tibial component</keyword>
  <keyword>all-polyethylene tibia</keyword>
  <keyword>modular polished tibial baseplate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Modular Metal Tibial Baseplate</title>
          <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA&#xD;
TKA surgery with modular polished tibial baseplate/XLK design: TKA surgery with modular polished tibial baseplate/XLK design&#xD;
P.F.C.® Sigma Knee System: P.F.C.® Sigma Knee System with modular XLK poly</description>
        </group>
        <group group_id="P2">
          <title>All Polyethylene Tibial Baseplate</title>
          <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.&#xD;
TKA surgery with the nonmodular APT/GVF design: TKA surgery with the nonmodular APT/GVF design&#xD;
P.F.C.® Sigma Knee System: P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</population>
      <group_list>
        <group group_id="B1">
          <title>Modular Metal Tibial Baseplate</title>
          <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA&#xD;
TKA surgery with modular polished tibial baseplate/XLK design: TKA surgery with modular polished tibial baseplate/XLK design&#xD;
P.F.C.® Sigma Knee System: P.F.C.® Sigma Knee System with modular XLK poly</description>
        </group>
        <group group_id="B2">
          <title>All Polyethylene Tibial Baseplate</title>
          <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.&#xD;
TKA surgery with the nonmodular APT/GVF design: TKA surgery with the nonmodular APT/GVF design&#xD;
P.F.C.® Sigma Knee System: P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                </category>
                <category>
                  <title>Asian</title>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                </category>
                <category>
                  <title>Black or African American</title>
                </category>
                <category>
                  <title>White</title>
                </category>
                <category>
                  <title>More than one race</title>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <class_list>
            <class>
              <title>United States</title>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding.</title>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical and Functional Outcomes Based on Standardized Validated TKA Outcome Instruments (KSS, KOOS, WOMAC, SF-36)</title>
        <description>Patient recorded outcome measures as noted</description>
        <time_frame>2 year follow-up intervals up to 20 years</time_frame>
        <population>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Modular Metal Tibial Baseplate</title>
            <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA&#xD;
TKA surgery with modular polished tibial baseplate/XLK design: TKA surgery with modular polished tibial baseplate/XLK design&#xD;
P.F.C.® Sigma Knee System: P.F.C.® Sigma Knee System with modular XLK poly</description>
          </group>
          <group group_id="O2">
            <title>All Polyethylene Tibial Baseplate</title>
            <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.&#xD;
TKA surgery with the nonmodular APT/GVF design: TKA surgery with the nonmodular APT/GVF design&#xD;
P.F.C.® Sigma Knee System: P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical and Functional Outcomes Based on Standardized Validated TKA Outcome Instruments (KSS, KOOS, WOMAC, SF-36)</title>
          <description>Patient recorded outcome measures as noted</description>
          <population>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wear Characteristics of the Standard GVF Polyethylene vs. the Moderately Cross-linked XLK Polyethylene</title>
        <description>Wear characteristics as above</description>
        <time_frame>2 year followup intervals to 20 years</time_frame>
        <population>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Modular Metal Tibial Baseplate</title>
            <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA&#xD;
TKA surgery with modular polished tibial baseplate/XLK design: TKA surgery with modular polished tibial baseplate/XLK design&#xD;
P.F.C.® Sigma Knee System: P.F.C.® Sigma Knee System with modular XLK poly</description>
          </group>
          <group group_id="O2">
            <title>All Polyethylene Tibial Baseplate</title>
            <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.&#xD;
TKA surgery with the nonmodular APT/GVF design: TKA surgery with the nonmodular APT/GVF design&#xD;
P.F.C.® Sigma Knee System: P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
          </group>
        </group_list>
        <measure>
          <title>Wear Characteristics of the Standard GVF Polyethylene vs. the Moderately Cross-linked XLK Polyethylene</title>
          <description>Wear characteristics as above</description>
          <population>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</desc>
      <group_list>
        <group group_id="E1">
          <title>Modular Metal Tibial Baseplate</title>
          <description>Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA&#xD;
TKA surgery with modular polished tibial baseplate/XLK design: TKA surgery with modular polished tibial baseplate/XLK design&#xD;
P.F.C.® Sigma Knee System: P.F.C.® Sigma Knee System with modular XLK poly</description>
        </group>
        <group group_id="E2">
          <title>All Polyethylene Tibial Baseplate</title>
          <description>Patients who were randomized to receive the nonmodular APT/GVF TKA design.&#xD;
TKA surgery with the nonmodular APT/GVF design: TKA surgery with the nonmodular APT/GVF design&#xD;
P.F.C.® Sigma Knee System: P.F.C. ® Sigma Knee System with an all-poly GVF tibia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>PI/study coordinator retired due to personal family health matters; study sponsor withdrew funding. Study terminated and no data collected or analyzed</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Terence Gioe M.D.</name_or_title>
      <organization>Minneapolis VAMC</organization>
      <phone>612-467-1780</phone>
      <email>tjgioe@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

